Cargando…

Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma

BACKGROUND: Pancreatic cancer is poorly characterized at genetic and non-genetic levels. The current study evaluates in a large cohort of patients the prognostic relevance of molecular subtypes and key transcription factors in pancreatic ductal adenocarcinoma (PDAC). METHODS: We performed gene expre...

Descripción completa

Detalles Bibliográficos
Autores principales: Janky, Rekin’s, Binda, Maria Mercedes, Allemeersch, Joke, Van den broeck, Anke, Govaere, Olivier, Swinnen, Johannes V., Roskams, Tania, Aerts, Stein, Topal, Baki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4983037/
https://www.ncbi.nlm.nih.gov/pubmed/27520560
http://dx.doi.org/10.1186/s12885-016-2540-6
_version_ 1782447847471316992
author Janky, Rekin’s
Binda, Maria Mercedes
Allemeersch, Joke
Van den broeck, Anke
Govaere, Olivier
Swinnen, Johannes V.
Roskams, Tania
Aerts, Stein
Topal, Baki
author_facet Janky, Rekin’s
Binda, Maria Mercedes
Allemeersch, Joke
Van den broeck, Anke
Govaere, Olivier
Swinnen, Johannes V.
Roskams, Tania
Aerts, Stein
Topal, Baki
author_sort Janky, Rekin’s
collection PubMed
description BACKGROUND: Pancreatic cancer is poorly characterized at genetic and non-genetic levels. The current study evaluates in a large cohort of patients the prognostic relevance of molecular subtypes and key transcription factors in pancreatic ductal adenocarcinoma (PDAC). METHODS: We performed gene expression analysis of whole-tumor tissue obtained from 118 surgically resected PDAC and 13 histologically normal pancreatic tissue samples. Cox regression models were used to study the effect on survival of molecular subtypes and 16 clinicopathological prognostic factors. In order to better understand the biology of PDAC we used iRegulon to identify transcription factors (TFs) as master regulators of PDAC and its subtypes. RESULTS: We confirmed the PDAssign gene signature as classifier of PDAC in molecular subtypes with prognostic relevance. We found molecular subtypes, but not clinicopathological factors, as independent predictors of survival. Regulatory network analysis predicted that HNF1A/B are among thousand TFs the top enriched master regulators of the genes expressed in the normal pancreatic tissue compared to the PDAC regulatory network. On immunohistochemistry staining of PDAC samples, we observed low expression of HNF1B in well differentiated towards no expression in poorly differentiated PDAC samples. We predicted IRF/STAT, AP-1, and ETS-family members as key transcription factors in gene signatures downstream of mutated KRAS. CONCLUSIONS: PDAC can be classified in molecular subtypes that independently predict survival. HNF1A/B seem to be good candidates as master regulators of pancreatic differentiation, which at the protein level loses its expression in malignant ductal cells of the pancreas, suggesting its putative role as tumor suppressor in pancreatic cancer. TRIAL REGISTRATION: The study was registered at ClinicalTrials.gov under the number NCT01116791 (May 3, 2010). ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-016-2540-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4983037
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49830372016-08-14 Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma Janky, Rekin’s Binda, Maria Mercedes Allemeersch, Joke Van den broeck, Anke Govaere, Olivier Swinnen, Johannes V. Roskams, Tania Aerts, Stein Topal, Baki BMC Cancer Research Article BACKGROUND: Pancreatic cancer is poorly characterized at genetic and non-genetic levels. The current study evaluates in a large cohort of patients the prognostic relevance of molecular subtypes and key transcription factors in pancreatic ductal adenocarcinoma (PDAC). METHODS: We performed gene expression analysis of whole-tumor tissue obtained from 118 surgically resected PDAC and 13 histologically normal pancreatic tissue samples. Cox regression models were used to study the effect on survival of molecular subtypes and 16 clinicopathological prognostic factors. In order to better understand the biology of PDAC we used iRegulon to identify transcription factors (TFs) as master regulators of PDAC and its subtypes. RESULTS: We confirmed the PDAssign gene signature as classifier of PDAC in molecular subtypes with prognostic relevance. We found molecular subtypes, but not clinicopathological factors, as independent predictors of survival. Regulatory network analysis predicted that HNF1A/B are among thousand TFs the top enriched master regulators of the genes expressed in the normal pancreatic tissue compared to the PDAC regulatory network. On immunohistochemistry staining of PDAC samples, we observed low expression of HNF1B in well differentiated towards no expression in poorly differentiated PDAC samples. We predicted IRF/STAT, AP-1, and ETS-family members as key transcription factors in gene signatures downstream of mutated KRAS. CONCLUSIONS: PDAC can be classified in molecular subtypes that independently predict survival. HNF1A/B seem to be good candidates as master regulators of pancreatic differentiation, which at the protein level loses its expression in malignant ductal cells of the pancreas, suggesting its putative role as tumor suppressor in pancreatic cancer. TRIAL REGISTRATION: The study was registered at ClinicalTrials.gov under the number NCT01116791 (May 3, 2010). ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-016-2540-6) contains supplementary material, which is available to authorized users. BioMed Central 2016-08-12 /pmc/articles/PMC4983037/ /pubmed/27520560 http://dx.doi.org/10.1186/s12885-016-2540-6 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Janky, Rekin’s
Binda, Maria Mercedes
Allemeersch, Joke
Van den broeck, Anke
Govaere, Olivier
Swinnen, Johannes V.
Roskams, Tania
Aerts, Stein
Topal, Baki
Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma
title Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma
title_full Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma
title_fullStr Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma
title_full_unstemmed Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma
title_short Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma
title_sort prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4983037/
https://www.ncbi.nlm.nih.gov/pubmed/27520560
http://dx.doi.org/10.1186/s12885-016-2540-6
work_keys_str_mv AT jankyrekins prognosticrelevanceofmolecularsubtypesandmasterregulatorsinpancreaticductaladenocarcinoma
AT bindamariamercedes prognosticrelevanceofmolecularsubtypesandmasterregulatorsinpancreaticductaladenocarcinoma
AT allemeerschjoke prognosticrelevanceofmolecularsubtypesandmasterregulatorsinpancreaticductaladenocarcinoma
AT vandenbroeckanke prognosticrelevanceofmolecularsubtypesandmasterregulatorsinpancreaticductaladenocarcinoma
AT govaereolivier prognosticrelevanceofmolecularsubtypesandmasterregulatorsinpancreaticductaladenocarcinoma
AT swinnenjohannesv prognosticrelevanceofmolecularsubtypesandmasterregulatorsinpancreaticductaladenocarcinoma
AT roskamstania prognosticrelevanceofmolecularsubtypesandmasterregulatorsinpancreaticductaladenocarcinoma
AT aertsstein prognosticrelevanceofmolecularsubtypesandmasterregulatorsinpancreaticductaladenocarcinoma
AT topalbaki prognosticrelevanceofmolecularsubtypesandmasterregulatorsinpancreaticductaladenocarcinoma